News archive
News Archive Navigation
icon
News Archive Navigation Language
Showing 678 results
December 2012
-
Media ReleaseNEJM published study shows Novartis compound ACZ885 significantly relieves symptoms in patients with serious form of childhood arthritis
-
Media ReleaseMultimedia Assets: Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder- As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease(1)- In the Phase III trial, most patients…
-
Media ReleaseMultimedia Assets: Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder
-
Media ReleaseNovartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder- As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease(1)- In the Phase III trial, most patients…
-
Media ReleaseNovartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder
November 2012
-
Media ReleaseNovartis Phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failureRELAX-AHF study met one of its two primary endpoints in reducing dyspnea or shortness of breath, and was therefore positive under pre-specified criteriaNewly presented data show that at six months,…
-
Media ReleaseNovartis Phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failure
October 2012
-
Media ReleaseLeeza Gibbons joins Novartis to improve caregiving experience for millions of Americans through real-world peer advice on AlzheimersDisease.com- Leeza and family share highs, lows and insights about caring for her mother with Alzheimer's disease in new video series- Ten national contest winners recognized for words of wisdom about finding…
-
Media ReleaseLeeza Gibbons joins Novartis to improve caregiving experience for millions of Americans through real-world peer advice on AlzheimersDisease.com
September 2012
-
Media ReleaseNovartis Pharmaceuticals Corporation emprende una campaña de educación de la comunidad hispana de EE. UU. sobre la enfermedad de AlzheimerLa iniciativa busca ayudar a cerrar la brecha del diagnóstico de los hispanos a través de recursos e información en español sobre la enfermedad de Alzheimer La compañía trabajará junto a Univision…
-
Media ReleaseNovartis Pharmaceuticals Corporation embarks on Alzheimer’s disease educational effort for the U.S. Hispanic communityThe initiative aims to help close diagnosis gap for Hispanic Americans by providing in-language information and resources focused on Alzheimer’s diseaseThe company will work with Univision to help…
-
Media ReleaseNovartis Pharmaceuticals Corporation emprende una campaña de educación de la comunidad hispana de EE. UU. sobre la enfermedad de Alzheimer
Pagination
- ‹ Previous page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- …
- 57
- › Next page